Handel nachbörslich: 1.88

Actinium Pharmaceuticals Inc (ATNM)

Actinium Pharmaceuticals Inc Aktie (ATNM) Neueste Nachrichten

Actinium Pharmaceuticals Inc (ATNM)

Actinium Pharmaceuticals Inc Aktie (ATNM) Neueste Nachrichten

S&P 500 Down Over 100 Points; Actinium Pharmaceuticals Shares Plunge - MSN

Comparing ARS Pharmaceuticals (NASDAQ:SPRY) & Actinium Pharmaceuticals (NYSE:ATNM) - Defense World

Actinium Pharmaceuticals (ATNM) vs. Its Rivals Head to Head Comparison - Defense World

Bank of New York Mellon Corp Increases Position in Actinium Pharmaceuticals, Inc. (NYSE:ATNM) - Defense World

Actinium Pharmaceuticals reports data from Phase III trial of AML treatment - Clinical Trials Arena

Actinium Pharmaceuticals, Inc. (NYSE:ATNM) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Actinium Pharmaceuticals, Inc. (NYSE:ATNM) Given Average Rating of “Moderate Buy” by Brokerages - Defense World

Stocks of the Hour: Amplia Therapeutics, Wellard, Anax Metals - ShareCafe

Stocks of the Hour: Amplia Therapeutics, Wellard, Anax Metals - Finance News Network

Before Buying Anterix Inc (NASDAQ: ATEX) Stock, Read This First - Stocks Register

Actinium Pharmaceuticals Announces Publication of Results from the Phase 3 SIERRA Trial of Iomab-B in the Journal of Clinical Oncology - PR Newswire

Australia's Amplia Therapeutics rises as US FDA fast-tracks cancer drug - XM

Applied Therapeutics: AdCom Decision Takes Govorestat Approval A Step Closer (NASDAQ:APLT) - Seeking Alpha

Stock Analysts’ Downgrades for September 18th (ATNM, BHR, CALX, FITB, MEDP, MMSI, MOH, MTRX, NPK, PRMW) - Defense World

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Actinium Pharmaceuticals, Inc.ATNM - PR Newswire

Lutetium-177 Industry Research Report 2024: Carrier Added Lutetium-177, Non-Carrier-Added Lutetium-177 - GlobeNewswire Inc.

ATNM: Riding the Market Waves of Growth and Decline in 2023 - The InvestChronicle

Actinium Pharmaceuticals Inc (ATNM) requires closer examination - US Post News

Market Highlights: Actinium Pharmaceuticals Inc (ATNM) Ends on a High Note at 1.99 - The Dwinnex

Analysts Set Actinium Pharmaceuticals, Inc. (NYSE:ATNM) PT at $11.43 - MarketBeat

Actinium Pharmaceuticals, Inc. (NYSE:ATNM) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World

Actinium Pharmaceuticals (NYSE:ATNM) Rating Increased to Hold at StockNews.com - MarketBeat

Quarterly Snapshot: Quick and Current Ratios for Actinium Pharmaceuticals Inc (ATNM) - The Dwinnex

ATNM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Actinium Pharmaceuticals, Inc. and Encourages Shareholders to Contact the Firm Today! - AccessWire

Actinium Pharmaceuticals (NYSE:ATNM) Downgraded to “Sell” at StockNews.com - Defense World

StockNews.com Downgrades Actinium Pharmaceuticals (NYSE:ATNM) to Sell - MarketBeat

ATNM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Actinium Pharmaceuticals, Inc. and Encourages Shareholders to Contact the Firm Today! - AccessWire

Taking on analysts’ expectations and winning: Actinium Pharmaceuticals Inc (ATNM) - SETE News

Actinium Pharmaceuticals, Inc. (ATNM) Investigation: - GlobeNewswire

ATNM STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Actinium Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm Today! - AccessWire

Did Actinium Pharmaceuticals Inc (ATNM) perform well in the last session? - US Post News

ATNM’s Stochastic Averages Dip: Analyzing Actinium Pharmaceuticals Inc’s Stock Performance - The InvestChronicle

Closing Strong: Actinium Pharmaceuticals Inc (ATNM) Ends at 1.82, Down -6.67 from Last Close - The Dwinnex

ATNM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Actinium Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm Today! - AccessWire

ATNM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Actinium Pharmaceuticals, Inc. and Encourages Stockholders to Contact the Firm! - AccessWire

Vanguard Group Inc. Buys 82,113 Shares of Actinium Pharmaceuticals, Inc. (NYSE:ATNM) - Defense World

Actinium Pharmaceuticals to Present at the 3rd Annual Targeted Radiopharmaceuticals Summit US - Longview News-Journal

ATNM STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Actinium Pharmaceuticals, Inc. and Encourages Shareholders to Contact the Firm! - AccessWire

Actinium Pharmaceuticals (NYSE:ATNM) Upgraded by StockNews.com to Hold - Defense World

Actinium Pharmaceuticals Inc Investors Urged To Participate In Fraud Investigation With The Schall Law Firm - WICZ

Actinium Pharmaceuticals (NYSE:ATNM) Lifted to "Hold" at StockNews.com - MarketBeat

ATNM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Actinium Pharmaceuticals, Inc. and Encourages Shareholders to Contact the Firm! - AccessWire

Get in on Actinium Pharmaceuticals Inc’s (ATNM) buy-in window today! - SETE News

ATNM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Actinium Pharmaceuticals, Inc. and Encourages Shareholders to Contact the Firm! - AccessWire

ATNM’s 2023 Market Dance: Down -59.65% – Time to Invest? - The InvestChronicle

Do investors need to be concerned about Actinium Pharmaceuticals Inc (ATNM)? - US Post News

Financial Health Check: Examining Actinium Pharmaceuticals Inc (ATNM)’s Key Ratios - The Dwinnex

Q3 2024 EPS Estimates for Actinium Pharmaceuticals, Inc. Raised by B. Riley (NYSE:ATNM) - MarketBeat

B. Riley Comments on Actinium Pharmaceuticals, Inc.’s Q3 2024 Earnings (NYSE:ATNM) - Defense World

ATNM STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Actinium Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm! - AccessWire

ATNM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Actinium Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm! - AccessWire

B. Riley Downgrades Actinium Pharmaceuticals (NYSE:ATNM) to Neutral - Defense World

ATNM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Actinium Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm! - AccessWire

Can Actinium Pharmaceuticals (ATNM) bounce back from the Regulatory Hurdles - BP Journal

Q3 2024 EPS Estimates for Actinium Pharmaceuticals, Inc. Increased by Analyst (NYSE:ATNM) - MarketBeat

ATNM Investors Have Opportunity to Join Actinium Pharmaceuticals, Inc. Fraud Investigation with the Schall Law Firm - Morningstar

Actinium Pharmaceuticals, Inc. to Post Q3 2024 Earnings of ($0.36) Per Share, HC Wainwright Forecasts (NYSE:ATNM) - Defense World

Ähnlich wie ATNM